Special Issue "New Insights into Systemic Lupus Erythematosus: From Immunopathogenesis to Treatment Strategies"
Deadline for manuscript submissions: 30 July 2019
Systemic Lupus Erytematosus (SLE) is an autoimmune disorder characterized by profound dysregulation of the innate and adaptive immune responses with the aberrant production of proinflammatory cytokines, generation of antinuclear antibodies and multiorgan damage. SLE patients are also at a significant risk of cardiovascular complications such as accelearated atherosclerosis largely driven by immune alterartions. Therefore, we are opening a Special Issue to compile the latest research in the following topics: innate and/or adaptive immune dysregulation, mechanisms leading to atherosclerosis, potential treatments/ personalized medicine, molecular and/or cellular aspects leading to SLE.
Comprehensive reviews, original articles or short communications are welcome.
We are looking forward to your contributions to this Special Issue.
Dr. Carmelo Carmona-Rivera
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- organ damage
- innate immunity